CVSA Covista Inc.

XNYS 116.50 Delayed
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

CVSA $116.50 —

What changed

Recent filings, trades and moves
Key stats
$116.50
52-Week Range
$94.11 – $142.13
YTD
+16.98%
IV Rank (30D)
16.21
Straddle Price
$11.55
P/C Vol Ratio
2.52
Market Cap
$3.8B
Open
$115.35
Day Range
$114.03 – $116.98
Volume
496,592
Prev Close
$113.98
Fair Value
MODEL: SHORT

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.84%
Beta vs SPY0.77
Cost of Equity (CAPM)8.67% (VRP-adj)
WACC7.91%
Volatility Risk Premium+19.8pp (IV − HV30)
Effective Tax Rate22.3%
Rev. Growth (YoY, DCF input)+3.0%
DCF Horizon12 years explicit + fade
Forward Tilt (NTM/TTM)×1.03 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$0.4B
Return on Equity (TTM)18.1%
Book / Price36.1% — banking bias active (P/B is primary)
Gross Margin (TTM)57.4%
FCF Margin (TTM)17.7%
Debt / Equity0.35
Quality Score4/6 — high quality (12y DCF)
Market-Implied Growth-4.5% (reverse-DCF on current price)
SMA 50$125.77 (Market Anchor value)
SMA 20 / Bollinger Mid$125.38
Bollinger Width / SMA2019.2% (drives anchor stability)
Net Debt$0.3B
Market Cap$4B
Peers used for multiples: LAUR, PFGC, SPHR (filtered from 8 ETF-co-members; sector bias active)
60-Day Conviction
46%
20-Day Fair Value
≈ by Dec 9, 2026
$115.28
α -0.6% rank 79%
conviction
44%
40-Day Fair Value
≈ by Jan 7, 2027
$116.58
α +0.5% rank 79%
conviction
21%
60-Day Fair Value
≈ by Feb 5, 2027
$113.97
α -1.7% rank 79%
conviction
46%
MethodImplied PriceWeightDetail
DCF $193.21 26%
DDM (Gordon) n/a 0%
Peer P/E n/a 0%
Peer EV/EBITDA $176.05 11% median 13.5× · 3 peers
Peer P/B $138.16 2% median 3.4× · 3 peers
Peer P/S $142.05 8% median 2.4× · 3 peers
Market Anchor (SMA50) $125.77 28% stability 54% (BB-width)
Options Expected (B-L 30d) $113.79 26% 23 strikes · skew +0.47
As of 2026-11-10 · updated
About
Industry (SIC)
SERVICES-EDUCATIONAL SERVICES (8200) · industry map
Exchange
XNYS
Market Cap
$3.8B
Employees
5,037
List Date
1991-06-21
CIK
0000730464
Last Earnings
Oct 29 after close · −3.4% vs ±11.9% expected
Next Earnings
~Jan 27, 2027 (estimated)
Headquarters
Chicago, IL
Homepage
https://www.covista.com

Covista Inc is America's healthcare educator across five accredited institutions: Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. It delivers education to its students at multiple campuses and online. Its segments are Chamberlain, Walden, and Medical and Veterinary. Walden generates maximum revenue and includes the operations of Walden, which offers degree and certificate programs, including those in nursing, education, counseling, business, information tec…

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
'26Avg
Jan----
Feb-1.60%-1.60%
Mar15.47%15.47%
Apr-1.23%-1.23%
May3.46%3.46%
Jun2.12%2.12%
Jul-4.03%-4.03%
Aug3.80%3.80%
Sep-8.52%-8.52%
Oct0.82%0.82%
Nov-6.53%*-6.53%
Dec----
Total1.82%1.82%
* Only 1 year(s) of data available.
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $124.75
SMA 50: $125.46
SMA 200: —
Current: $116.50
EMA 12: $120.18
EMA 26: $123.35
MACD: -3.1659 | Signal: -1.6091
BEARISH
ADX (14): 28.32
TREND
+DI: 12.61
−DI: 31.04

Momentum Oscillators

RSI (14): 39.30
NEUTRAL
Stoch %K: 23.36
Stoch %D: 21.57
Williams %R: -65.63

Volume & Volatility

BB Upper: $137.24
BB Lower: $112.25
NEUTRAL
OBV: 2,220,654
Vol SMA 20: 437,064
Vol ROC: 21.14%
ATR: $5.63
True Range: $3.00
HV 20: 44.8%
HV 30: 38.9%
HV 60: 35.2%

Data Summary

Data Points: 181
Last Updated:
Date Range: 2026-02-24T00:00:00 – 2026-11-10T00:00:00
AI Analysis
Written before CVSA’s Oct 29 earnings report, so it doesn’t reflect the results.

Here is the comprehensive stock analysis for CVSA:

Executive Summary

Overall assessment: NEUTRAL with a confidence level of 6 (out of 10)

Key drivers and primary risks:

  • Strong technical momentum signals from MACD, RSI, and Stochastic indicators
  • Negative sentiment from recent news headlines, CEO's share sale, and lower volume
  • Low volatility and historical volatility metrics indicate a potentially overbought market

Investment thesis: CVSA is experiencing strong technical momentum, but may be overbought due to recent negative news and low volatility. A potential pullback or consolidation phase could provide a buying opportunity.

Recent news sentiment impact: Negative sentiment from the CEO's share sale and lower volume may weigh on the stock price in the short term.

Technical Analysis

Trend Direction: Short-term (1-4 weeks) = Uptrend, Medium-term (1-3 months) = Neutral, Long-term (3-12 months) = Neutral

Support/Resistance Levels: Key levels to monitor are $132.06 (SMA 20), $130.92 (EMA 26), and $125.02 (Lower Bollinger Band)

Momentum Signals:

  • RSI interpretation: 46.50 (neutral)
  • MACD signal: Bullish
  • Bollinger Bands position: Neutral

Volume Analysis: Volume trends suggest institutional interest is low, with a volume rate of change of -39.66%.

News & Sentiment Analysis

Recent Headlines Summary: Key themes are CEO's share sale and lower volume.

Sentiment Assessment: Aggregate news sentiment is NEUTRAL, with 1 out of 10 headlines being negative.

Catalyst Identification: No upcoming earnings or product launches to impact the stock price.

Market Narrative: News sentiment contradicts technical signals, indicating a potential pullback or consolidation phase.

Risk & Volatility Assessment

Beta Interpretation: Beta is -0.18, indicating that CVSA moves opposite to the market.

Volatility Regime: Current volatility is low, with historical volatility metrics indicating an overbought market.

Options Market Signals: IV Rank is 9.3%, indicating historically low volatility. Options market pricing a $12.80 move by expiration.

Downside Protection: Support levels and risk management considerations should focus on the Lower Bollinger Band ($125.02) and SMA 20 ($132.06).

Market Context & Positioning

Sector Performance: CVSA is outperforming its sector in the short term, but underperforming in the long term.

Institutional Activity: Institutional interest is low, with a volume rate of change of -39.66%.

Correlation Analysis: CVSA has a negative correlation (-0.05) to the market, indicating it may not follow broader market trends.

Relative Valuation: CVSA is trading within its historical range, but may be overbought in the short term.

Key Levels & Action Items

Critical Price Levels: Monitor SMA 20 ($132.06), EMA 26 ($130.92), and Lower Bollinger Band ($125.02).

Breakout/Breakdown Levels: A breakout above $139.11 (Upper Bollinger Band) or a breakdown below $125.02 (Lower Bollinger Band) could trigger significant moves.

Time-Sensitive Catalysts: No upcoming earnings or product launches to impact the stock price in the near term.

Risk Management: Consider stop-loss levels at SMA 20 ($132.06) and risk management considerations based on recent news sentiment and technical signals.

Please note that this analysis is for informational purposes only and should not be taken as investment advice.

Generated
News
All CVSA news →
Earnings History
1 of 3 under expected move
Avg Expected Move
11.62%
Avg Actual Move
10.40%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2026-05-07 After-Close 11.11% 14.30% 1.29x Exceeded
2026-08-06 After-Close 11.83% 13.46% 1.14x Exceeded
2026-10-29 After-Close 11.92% 3.44% 0.29x Within

Earnings calendar: this week’s reports with expected vs actual moves →

CVSA Options Activity & IV Rank

CVSA IV rank history, 52-week IV rank and IV percentile →

Volatility Metrics

Current IV: 39.7%
7-DTE IV: 45.6%
Expected Move: $11.55
7-DTE Move: $7.40
Days to Exp: 38 (2026-12-18)

Options Flow · All expiries

Call Volume: 452
Put Volume: 1,139
P/C Volume: 2.52
BEARISH
Call OI: 1,862
Put OI: 1,435
P/C OI: 0.771
Total OI: 3,297

ATM Options Pricing

ATM Call: $6.55
ATM Put: $5.00
Call %: 5.6%
Put %: 4.3%

Chain Summary

Chain Volume: 1,591
Chain OI: 3,297
Last Updated: 11/10/2026
Spread Scanner
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Scanning bull put, bear call, iron condor and calendar spreads…

Dealer Positioning
LOW γ vs HISTORY

Estimated net dealer gamma is at the 7th percentile of this name's own daily history, near the low end of its range. This describes current positioning; it is not a forecast or a trading signal.

Gamma percentile
7%
vs own history
GEX tilt
-0.25
OI-weighted, today
Vanna tilt
+0.20
δ-sensitivity to IV
Charm tilt
-0.24
δ-decay vs time

Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.

Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.

Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.

This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.

· 13 ATM contracts, 0k total OI
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
as of Nov 10 · No data
30 DTE / 10d —
— pts EXTREME
as of Nov 10 · No data

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Loading the implied volatility surface…

Volatility Smile

Loading the implied volatility smile…

IV Rank (7 DTE)28.6MediumNov 10
IV Rank (30 DTE)16.2LowNov 10

Embed CVSA IV rank

CVSA's 30-day IV rank (90 sessions) with its 52-week rank, at-the-money IV and a 90-session trend. Updates after each close. Paste the code into any web page or blog post. Email newsletters drop iframes, so link to the page there.

Theme
Preview
Straddle Price (30 DTE)$11.55Nov 10
Beta Analysis

Risk Metrics

Beta: 0.2086
Alpha: 29.25%
Correlation: 0.0652
R-Squared: 0.4%
Stock Volatility: 46.3%
Market Volatility: 14.5%

Analysis Details

Benchmark: SPY
Data Points: 180
Period: 252 trading days
Interpretation:
Low volatility - stock moves less than market
Beta & Alpha Over Time
Notable investors who own CVSA
4 of 37 tracked investors
InvestorValueShare of their portfolioRankQ/Q sharesSource
Millennium Management Hedge fund
Izzy Englander
$9.7M
0.01%
#1597 of 3716-5.8%13F
Renaissance Technologies Hedge fund
Jim Simons
$2.7M
0.00%
#1798 of 3138-56.5%13F
Bridgewater Associates Hedge fund
Ray Dalio
$2.1M
0.01%
#699 of 997+16.3%13F
Rockefeller Capital Management Family office
Rockefeller family
$8K
0.00%
#4086 of 4729-74.0%13F

Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions

CVSA Institutional Ownership (13F)

Filings for 2026-06-30 · 171 already for 2026-09-30
Diluted shares outstanding: 35,094,000 (as of 2026-09-30)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

392 filers68,798,760 shares$8.55B value196.04% of float
# Filer Shares Value % of Total % of Float Period
1 BlackRock, Inc. Custodian 10,960,652 $1.37B 15.98% 31.23% 2026-06-30
2 FMR LLC Custodian 6,436,406 $802.36M 9.38% 18.34% 2026-06-30
3 Vanguard Portfolio Management LLC 4,773,916 $595.12M 6.96% 13.60% 2026-06-30
4 Dimensional Fund Advisors LP Custodian 3,709,998 $453.34M 5.30% 10.57% 2026-09-30
5 ARIEL INVESTMENTS, LLC 3,543,688 $441.76M 5.17% 10.10% 2026-06-30
6 Vanguard Capital Management LLC 2,947,896 $367.48M 4.30% 8.40% 2026-06-30
7 State Street Corp 2,778,954 $346.42M 4.05% 7.92% 2026-06-30
8 Capital World Investors 2,127,286 $265.19M 3.10% 6.06% 2026-06-30
9 Geode Capital Management, LLC Custodian 1,763,654 $215.56M 2.52% 5.03% 2026-09-30
10 Wellington Management Group LLP Custodian 1,604,110 $199.97M 2.34% 4.57% 2026-06-30
11 T. Rowe Price Associates, Inc. 1,535,868 $191.46M 2.24% 4.38% 2026-06-30
12 Arrowstreet Capital, Limited Partnership 1,260,730 $157.16M 1.84% 3.59% 2026-06-30
13 Boston Partners 1,134,344 $142.46M 1.67% 3.23% 2026-06-30
14 Franklin Resources, Inc. Custodian 1,134,510 $141.43M 1.65% 3.23% 2026-06-30
15 Alyeska Investment Group, L.P. 1,103,922 $137.61M 1.61% 3.15% 2026-06-30
16 LSV ASSET MANAGEMENT 1,120,060 $136.87M 1.60% 3.19% 2026-09-30
17 Fisher Asset Management, LLC 1,083,500 $132.40M 1.55% 3.09% 2026-09-30
18 Charles Schwab Investment Management, Inc. 966,552 $120.49M 1.41% 2.75% 2026-06-30
19 Morgan Stanley Custodian 945,960 $117.92M 1.38% 2.70% 2026-06-30
20 Northern Trust Corp Custodian 869,976 $108.45M 1.27% 2.48% 2026-06-30
21 NEUMEIER POMA INVESTMENT COUNSEL LLC 706,094 $88.02M 1.03% 2.01% 2026-06-30
22 FRONTIER CAPITAL MANAGEMENT CO LLC 605,308 $75.46M 0.88% 1.72% 2026-06-30
23 AQR Capital Management, LLC Custodian 543,904 $66.75M 0.78% 1.55% 2026-06-30
24 Two Sigma Investments, LP Custodian 518,886 $64.68M 0.76% 1.48% 2026-06-30
25 Vanguard Fiduciary Trust Co 488,326 $60.87M 0.71% 1.39% 2026-06-30
5 filers$9.97M notional
# Filer Notional Value % of Total Period
1 Citadel Advisors LLC Custodian $4.21M 42.26% 2026-06-30
2 Susquehanna International Group, LLP Custodian $3.96M 39.76% 2026-06-30
3 Jane Street Group, LLC Custodian $1.05M 10.50% 2026-06-30
4 IMC-Chicago, LLC Custodian $708.76K 7.11% 2026-09-30
5 Simplex Trading, LLC Custodian $36.66K 0.37% 2026-09-30
3 filers$5.86M notional
# Filer Notional Value % of Total Period
1 Susquehanna International Group, LLP Custodian $2.32M 39.57% 2026-06-30
2 Jane Street Group, LLC Custodian $2.14M 36.60% 2026-06-30
3 Citadel Advisors LLC Custodian $1.40M 23.83% 2026-06-30

CVSA Insider Trading (Form 4)

Latest: 2026-10-16
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-10-16 Leslie Storms Director Award (A) +259 $127.24 $33.0K EDGAR
2026-10-16 Sara Hill CHRO Tax (F) −1,322 $127.24 -$168.2K EDGAR
2026-10-16 Emily C Chiu Director Award (A) +259 $127.24 $33.0K EDGAR
2026-10-09 Stephen W. Beard Chairman & CEO Sell (S) −8,306 $130.59 -$1.08M EDGAR
2026-09-01 Michael W Malafronte Director Gift (G) −2,500 — EDGAR
2026-08-28 Manjunath Gangadharan VP, Chief Accounting Officer Sell (S) −1,802 $137.18 -$247.2K EDGAR
2026-08-25 Manjunath Gangadharan VP, Chief Accounting Officer Mixed
Grant +2,550 · Tax −936
 +1,614 $132.35 $213.6K EDGAR
2026-08-25 Stephen W. Beard Chairman & CEO Mixed
Tax −66,797 · Grant +129,064
 +62,267 $132.35 $8.24M EDGAR
2026-08-25 Robert J. Phelan Chief Financial Officer Mixed
Tax −8,871 · Grant +17,136
 +8,265 $132.35 $1.09M EDGAR
2026-08-25 Michael Betz Pres. Walden University & CDO Mixed
Grant +12,444 · Tax −6,558
 +5,886 $132.35 $779.0K EDGAR
2026-08-25 Douglas G. Beck SVP, GC, Corp. Sec & ISS Mixed
Grant +10,302 · Tax −5,452
 +4,850 $132.35 $641.9K EDGAR
2026-08-13 Stephen W. Beard Chairman & CEO Sell (S) −3,545 $130.34 -$462.1K EDGAR
2026-08-11 Robert J. Phelan Chief Financial Officer Sell (S) −2,186 $135.15 -$295.4K EDGAR
2026-08-11 Douglas G. Beck SVP, GC, Corp. Sec & ISS Sell (S) −4,526 $135.81 -$614.7K EDGAR
2026-07-16 Amelia Manning President, Chamberlain Univ. Award (A) +4,317 $115.82 $500.0K EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

CVSA Insider Holdings

12 insiders · @ $116.50
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Stephen W. Beard Chairman & CEO 473,825 $55.20M -$5.02M 6 2026-10-09
2 Michael W Malafronte Director 136,100 $15.86M $3.75M 3 2026-09-01
3 Robert J. Phelan Chief Financial Officer 54,083 $6.30M -$2.28M 4 2026-08-25
4 Michael Betz Pres. Walden University & CDO 41,483 $4.83M $0 1 2026-08-25
5 Douglas G. Beck SVP, GC, Corp. Sec & ISS 32,002 $3.73M -$2.52M 4 2026-08-25
6 Karen Sue Cox President, Chamberlain Univ. 31,596 $3.68M -$249.0K 1 2026-05-12
7 Scott Liles President, Medical and Vet 13,103 $1.53M $0 1 2026-04-16
8 Sara Hill CHRO 8,954 $1.04M $0 1 2026-10-16
9 Manjunath Gangadharan VP, Chief Accounting Officer 5,083 $592.2K -$247.2K 3 2026-08-28
10 Amelia Manning President, Chamberlain Univ. 4,317 $502.9K $0 1 2026-07-16
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.

CVSA Board & Officers

As of SEC filings through Oct 16, 2026

Directors 11

Officers 12

Changes in the last 10 years (75)
Aug 17, 2026Leslie Storms became a director
Aug 17, 2026Emily C Chiu became a director
May 18, 2026Amelia Manning became President, Chamberlain Univ.
Aug 27, 2025Stephen W. Beard listed as Chairman & CEO (previously President and CEO) in SEC filings
May 12, 2025Megan Noel became Chief Corp. Affairs Officer
Feb 7, 2025Michael Betz listed as Pres. Walden University & CDO (previously President, Walden University) in SEC filings
Nov 15, 2024Evan Trent listed as President, Adtalem Elevate (previously SVP, Chief Strat. & Transform) in SEC filings
Nov 13, 2024Mayur Gupta reported in an SEC filing no longer being a director
Sep 9, 2024Sara Hill became CHRO
Aug 27, 2024Blake Simpson listed as SVP, Chief Comms & CA Officer (previously SVP, Chief Comms Officer) in SEC filings
Apr 10, 2024The company announced the departure of John W Md Danaher as Pres. - Adtalem Med & Vet in an SEC filing
Apr 1, 2024Scott Liles became President, Medical and Vet
Jan 8, 2024Betty M. Vandenbosch became a director
Nov 13, 2023Charles DeShazer reported in an SEC filing no longer being a director
Aug 29, 2023Douglas G. Beck listed as SVP, GC, Corp. Sec & ISS (previously SVP, GC & Corp. Secretary) in SEC filings
Aug 25, 2023Maurice Herrera listed as SVP - Chief Marketing Officer (previously Chief Marketing Officer) in SEC filings
Dec 5, 2022Blake Simpson became SVP, Chief Comms Officer
Nov 10, 2022Lyle Logan reported in an SEC filing no longer being a director
Nov 9, 2022Lisa W Wardell first listed as a director in an SEC filing
Aug 24, 2022Evan Trent became SVP, Chief Strat. & Transform
Not reported recently (26)
  • Blake Simpson · Last reported as SVP, Chief Comms & CA Officer in an SEC filing dated Dec 6, 2024
  • Steven Tom · Last reported as SVP Chief Customer Officer in an SEC filing dated Nov 15, 2024
  • Cheryl James · Last reported as SVP, CHRO in an SEC filing dated Feb 29, 2024
  • James Raymond Bartholomew · Last reported as SVP - Chamberlain University in an SEC filing dated Aug 30, 2022
  • Paula R Singer · Last reported as President Walden University in an SEC filing dated Sep 17, 2021
  • Holland Katherine Alice Boden · Last reported as Group Pres, Adtalem Health in an SEC filing dated Aug 31, 2021
  • Donna Jennings · Last reported as SVP, Human Resources in an SEC filing dated Aug 30, 2021
  • Christopher C Nash · Last reported as SVP, Chief Information Officer in an SEC filing dated Aug 30, 2021
  • Fernando Lau · Last reported as SVP, Chief Marketing Officer in an SEC filing dated Aug 30, 2021
  • Chaka M Patterson · Last reported as SVP and General Counsel in an SEC filing dated Aug 31, 2020
  • Thiago Aguiar Sayao · Last reported as Group President, Business &Law in an SEC filing dated Feb 28, 2020
  • Mehul R Patel · Last reported as Group Pres, Financial Services in an SEC filing dated Nov 12, 2019
  • Steven Altschuler · Last reported as a director in an SEC filing dated Nov 7, 2019
  • Lisa M Sodeika · Last reported as SVP, Corporate Affairs in an SEC filing dated Aug 30, 2019
  • Kathleen Carroll · Last reported as Vice President, Controller in an SEC filing dated Aug 30, 2019
  • Catherine C. Anderson · Last reported as SVP, Strategy & Innovation in an SEC filing dated Aug 28, 2019
  • Carlos Filgueiras · Last reported as Group President, Tech/Business in an SEC filing dated Feb 14, 2019
  • Ann Hart · Last reported as a director in an SEC filing dated Nov 9, 2018
  • Donna M Loraine · Last reported as President, Carrington Colleges in an SEC filing dated Nov 7, 2018
  • Susan Groenwald · Last reported as President, Chamberlain in an SEC filing dated Feb 12, 2018
  • John P Roselli · Last reported as President, Becker Professional in an SEC filing dated Sep 5, 2017
  • Eric P. Dirst · Last reported as President, ATGE Shared Ops in an SEC filing dated Aug 31, 2017
  • Robert A Paul · Last reported as President, DeVry University in an SEC filing dated Aug 28, 2017
  • Gena L Ashe · Last reported as SVP, CLO and Secretary in an SEC filing dated Aug 24, 2017
  • Fernando Ruiz · Last reported as a director in an SEC filing dated Nov 14, 2016
  • Christopher B Begley · Last reported as a director in an SEC filing dated Nov 14, 2016
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.

CVSA Proposed Insider Sales (Form 144)

Latest: 2026-10-09
Last 30d: 1 filing · $604K notice value  ·  Last 90d: 4 filings · $1.8M notice value · 2 unique filers · 100% under 10b5-1 plans

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.

Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.

Top 90-day filers: Stephen Beard (3, $1.5M) · MANJUNATH GANGADHARAN (1, $248K)
Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2026-10-09 Stephen Beard Director 4,667 $603.8K 2026-10-09 Goldman Sachs & Co. LLC 10b5-1 EDGAR
2026-10-08 Stephen Beard Director 3,639 $474.1K 2026-10-08 Goldman Sachs & Co. LLC 10b5-1 EDGAR
2026-08-27 MANJUNATH GANGADHARAN Officer 1,802 $248.3K 2026-08-27 Morgan Stanley Smith Barney LLC … 10b5-1 EDGAR
2026-08-11 Stephen Beard Director 3,545 $448.4K 2026-08-11 Goldman Sachs & Co. LLC 10b5-1 EDGAR
2026-07-13 Stephen Beard Director 5,291 $704.7K 2026-07-13 Goldman Sachs & Co. LLC 10b5-1 EDGAR
2026-07-07 ROBERT PHELAN Officer 7,500 $971.7K 2026-07-07 Morgan Stanley Smith Barney LLC … 10b5-1 EDGAR
2026-07-07 DOUGLAS BECK Officer 9,615 $1.25M 2026-07-07 Morgan Stanley Smith Barney LLC … 10b5-1 EDGAR
2026-06-11 Stephen Beard Director 2,529 $333.5K 2026-06-11 Goldman Sachs & Co. LLC 10b5-1 EDGAR
2026-06-10 Stephen Beard Director 2,762 $359.8K 2026-06-10 Goldman Sachs & Co. LLC 10b5-1 EDGAR
2026-05-08 Stephen Beard Officer 15,874 $2.12M 2026-05-08 Goldman Sachs & Co. LLC 10b5-1 EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
Recent SEC Filings
Latest: 2026-10-29
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
Filing Date Event Link
2026-10-29 Earnings results EDGAR
2026-09-23 Material agreement · New debt obligation EDGAR
2026-08-06 Earnings results EDGAR
2026-07-28 Director or officer change EDGAR
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
Filing Date Accession Link
2026-08-06 0001104659-26-092044 EDGAR
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
Filing Date Accession Link
2026-10-29 0001104659-26-120213 EDGAR
ETF Holders
121 ETFs hold CVSA
25 shown · $1.06B total exposure · 0.21% AUM-weighted avg weight
# ETF Provider Weight $ Exposure ETF AUM As Of
1 IJR iShares Core S&P Small-Cap ETF iShares (BlackRock) 0.22% $227.2M $106.7B 2026-11-06
2 VTI Vanguard Morningstar Total Stock Market ETF Vanguard 0.01% $125.9M — 2026-09-30
3 IWM iShares Russell 2000 ETF iShares (BlackRock) 0.13% $97.4M $77.9B 2026-11-06
4 VB Vanguard Morningstar Small-Cap ETF Vanguard 0.05% $88.9M — 2026-09-30
5 DFAT Dimensional US Targeted Value ETF Dimensional 0.20% $60.4M — 2026-11-06
6 VBR Vanguard Morningstar Small-Cap Value ETF Vanguard 0.09% $57.9M — 2026-09-30
7 VXF Vanguard Extended Market ETF Vanguard 0.05% $46.9M — 2026-09-30
8 DFAS Dimensional US Small Cap ETF Dimensional 0.12% $40.9M — 2026-11-06
9 IWO iShares Russell 2000 Growth ETF iShares (BlackRock) 0.26% $35.4M $14.2B 2026-11-06
10 SPSM State Street® SPDR® Portfolio S&P 600™ Small Cap ETF SPDR (State Street) 0.22% $34.7M $15.7B 2026-11-06
11 IJT iShares S&P Small-Cap 600 Growth ETF iShares (BlackRock) 0.47% $33.9M $7.5B 2026-11-06
12 DFMC Dimensional US Micro Cap ETF Dimensional 0.39% $29.2M — 2026-11-06
13 CGMM Capital Group U.S. Small and Mid Cap ETF Capitalgroup 0.74% $26.4M $3.6B 2026-11-06
14 VTWO Vanguard Russell 2000 ETF Vanguard 0.14% $24.1M — 2026-09-30
15 SLYG State Street® SPDR® S&P 600™ Small Cap Growth ETF SPDR (State Street) 0.47% $21.5M $4.6B 2026-11-06
16 SCHA Schwab U.S. Small-Cap ETF Nport 0.09% $21.4M — 2026-08-31
17 DFAC Dimensional US Core Equity 2 ETF Dimensional 0.02% $18.1M — 2026-11-06
18 VIOO Vanguard S&P Small-Cap 600 ETF Vanguard 0.24% $14.7M — 2026-09-30
19 FNDA Schwab Fundamental U.S. Small Company ETF Nport 0.16% $14.6M — 2026-08-31
20 VCR Vanguard Consumer Discretionary ETF Vanguard 0.13% $8.1M — 2026-09-30
21 DCOR Dimensional US Core Equity 1 ETF Dimensional 0.02% $7.5M — 2026-11-06
22 JSMD Janus Henderson Small/Mid Cap Growth Alpha ETF Janus 0.70% $7.1M $1.0B 2026-11-06
23 AVSC Avantis U.S. Small Cap Equity ETF Avantis 0.21% $6.7M $3.2B 2026-11-06
24 PRFZ Invesco RAFI US 1500 Small-Mid ETF Nport 0.24% $6.5M — 2026-07-31
25 PSC Principal U.S. Small-Cap ETF Nport 0.24% $5.6M — 2026-06-30
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

Trailing P/E
15.92
TTM Diluted EPS
$7.32
TTM Revenue
$2.00B
TTM Net Income
$257.16M
TTM Op. Cash Flow
$453.91M
Quarterly figures (3 quarters)
QuarterPeriod EndRevenueNet IncomeDiluted EPSOp. Cash Flow
Q1 '272026-09-30$511.53M$67.43M$1.95$114.04M
Q4 '262026-06-30$501.38M$71.72M$2.05$123.96M
Q3 '262026-03-31$487.03M$41.64M$1.20$186.17M
Q1 2027 • period ending 2026-09-30 • filed 2026-10-29
Valuation

Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.

Price Multiples
  • P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
  • P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
  • P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
  • EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
  • EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
  • ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
  • ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
  • Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
  • FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
  • Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
  • Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
  • Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
  • Multiples expanding while earnings are flat = sentiment-driven rally.
  • Multiples compressing while earnings grow = value coming from fundamentals.
P/E
15.92
P/B
2.90
P/S
2.14
EV/EBITDA
9.98
EV/Sales
2.27
ROE
17.4%
ROA
8.4%
Div Yield
0.00%
FCF Yield
11.23%
Debt/Equity
0.45
Current Ratio
—
Market Cap
$4.19B
as of 2026-11-10

CVSA vs Peers

Related companies, largest first
Company Market cap P/E Revenue growth YTD IV rank
COST Costco Wholesale Corp $472.5B 51.4 +10.1% +24.8% 82
CHD Church & Dwight Co., Inc. $26.3B 35.8 +2.7% +35.2% 44
CASY Casey's General Stores Inc $25.6B 33.6 +13.8% +25.6% 70
USFD US Foods Holding Corp. $23.6B 33.8 +3.8% +47.2% 22
PFGC Performance Food Group Company $17.6B 48.7 +7.2% +26.1% 35
LAUR Laureate Education, Inc. Common Stock $4.7B 13.0 +20.9% +5.0% 62
SPHR Sphere Entertainment Co. $4.4B — +36.3% +29.6% 42
CVSA Covista Inc. $3.8B 15.9 — +17.0% 16
LIND Lindblad Expeditions Holdings Inc. Commo $2.3B — +16.7% +144.9% 58
Peer median $20.6B 34.8 +11.9% +27.8% 51

P/E uses the latest reported trailing-12-month diluted EPS; "—" means no positive earnings or no data.

Short Interest & Float

Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.

Metric definitions
  • Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
  • SI % of Float — short interest / free float. The key crowding metric.
  • Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
  • Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
  • Free Float — shares available for public trading (total shares minus insider / restricted).
  • Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
  • SI % of Float < 5% — typical, no particular signal.
  • 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
  • 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
  • >30% — extreme; borrow is likely expensive and squeeze risk is material.
  • Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
  • Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
  • A sudden drop in SI after a rally may indicate a squeeze in progress.

Short interest is reported mid-month and end-of-month; short volume is daily.

Short Interest
2.78M
SI % of Float
8.38%
Days to Cover
9.85
Short Vol Ratio
80.0%
Free Float
33.15M
Float %
97.4%
Short interest 2026-10-15 • Short volume 2026-11-10 • Float 2026-09-22